First Premier Bank Bristol Myers Squibb CO Transaction History

First Premier Bank

$401 Million
Q3 2024

A detailed history of First Premier Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Premier Bank holds 4,079 shares of BMY stock, worth $231,850. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,079

Previous 6,757 39.63%

Holding current value

$231,850

Previous $280,000 24.64%

% of portfolio

0.05%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$39.66 - $51.75 $106,209 - $138,586	-2,678 Reduced 39.63%	4,079 $211,000
Q2 2024 Jul 17, 2024	SELL	$40.25 - $52.99 $143,813 - $189,333	-3,573 Reduced 34.59%	6,757 $280,000
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $28,068 - $31,824	-585 Reduced 5.36%	10,330 $561,000
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $13,962 - $16,660	-288 Reduced 2.57%	10,915 $560,000
Q3 2023 Oct 16, 2023	SELL	$57.89 - $64.73 $29,234 - $32,688	-505 Reduced 4.31%	11,203 $674,000
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $174,883 - $194,181	-2,745 Reduced 18.99%	11,708 $749,000
Q1 2023 Apr 10, 2023	SELL	$65.71 - $74.53 $3,285 - $3,726	-50 Reduced 0.34%	14,453 $1 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $5,136 - $6,081	-75 Reduced 0.51%	14,503 $1.04 Million
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $14 - $8,452	110 Added 0.76%	14,578 $1.04 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $35,002 - $38,550	-482 Reduced 3.22%	14,468 $1.11 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $57,606 - $69,075	937 Added 6.69%	14,950 $1.09 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $10,457 - $12,191	-195 Reduced 1.37%	14,013 $873,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $44,081 - $51,635	745 Added 5.53%	14,208 $840,000
Q2 2021 Jul 14, 2021	BUY	$61.91 - $67.42 $66,243 - $72,139	1,070 Added 8.63%	13,463 $900,000
Q4 2020 Jan 12, 2021	BUY	$57.74 - $65.43 $179,167 - $203,029	3,103 Added 33.4%	12,393 $769,000
Q3 2020 Oct 06, 2020	BUY	$57.43 - $63.64 $4,020 - $4,454	70 Added 0.76%	9,290 $560,000
Q2 2020 Jul 07, 2020	BUY	$54.82 - $64.09 $30,151 - $35,249	550 Added 6.34%	9,220 $542,000
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $11,958 - $15,598	243 Added 2.88%	8,670 $557,000
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $8,554 - $10,142	-200 Reduced 2.32%	8,427 $427,000
Q2 2019 Jul 09, 2019	SELL	$44.62 - $49.34 $8,924 - $9,868	-200 Reduced 2.27%	8,627 $392,000
Q1 2019 Apr 04, 2019	BUY	$45.12 - $53.8 $61,814 - $73,706	1,370 Added 18.37%	8,827 $421,000
Q4 2018 Jan 14, 2019	BUY	$48.76 - $63.23 $9,752 - $12,646	200 Added 2.76%	7,457 $387,000
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $4,139 - $4,668	75 Added 1.04%	7,257 $451,000
Q2 2018 Jul 10, 2018	BUY	$50.53 - $62.98 $23,496 - $29,285	465 Added 6.92%	7,182 $398,000
Q1 2018 Apr 09, 2018	BUY	$59.92 - $68.98 $26,964 - $31,041	450 Added 7.18%	6,717 $425,000
Q4 2017 Jan 11, 2018	SELL	$59.94 - $65.35 $11,388 - $12,416	-190 Reduced 2.94%	6,267 $384,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $356,620 - $411,569	6,457	6,457 $412,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.

Account

First Premier Bank Bristol Myers Squibb CO Transaction History